These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6752035)
21. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. Marks MI; Ziegler EJ; Douglas H; Corbeil LB; Braude AI J Clin Invest; 1982 Apr; 69(4):742-9. PubMed ID: 7042755 [TBL] [Abstract][Full Text] [Related]
22. Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum. Ziegler EJ; McCutchan JA; Douglas H; Braude AI Trans Assoc Am Physicians; 1975; 88():101-8. PubMed ID: 772922 [TBL] [Abstract][Full Text] [Related]
23. Ineffectiveness of single-dose human antiserum to core glycolipid (E. coli J5) for prophylaxis of bacteremic, gram-negative infections in patients with prolonged neutropenia. McCutchan JA; Wolf JL; Ziegler EJ; Braude AI Schweiz Med Wochenschr Suppl; 1983; 14():40-5. PubMed ID: 6361990 [TBL] [Abstract][Full Text] [Related]
24. Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli. Raponi G; Lun MT; Lorino G; Nazzari C; Gaeta A; Mancini C; Filadoro F J Antimicrob Chemother; 1993 Jan; 31(1):117-28. PubMed ID: 8444656 [TBL] [Abstract][Full Text] [Related]
25. Role of normal serum in the binding of lipopolysaccharide to IgG fractions from rabbit antisera to Escherichia coli J5 and other gram-negative bacteria. Warren HS; Glennon M; de Deckker FA; Tello D J Infect Dis; 1991 Jun; 163(6):1256-66. PubMed ID: 1709961 [TBL] [Abstract][Full Text] [Related]
26. Effect of immunization with Escherichia coli J5 on graft-versus-host disease induced by minor histocompatibility antigens in mice. Moore RH; Lampert IA; Chia Y; Aber VR; Cohen J Transplantation; 1987 Aug; 44(2):249-53. PubMed ID: 3307049 [TBL] [Abstract][Full Text] [Related]
27. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria. Siber GR; Kania SA; Warren HS J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146 [TBL] [Abstract][Full Text] [Related]
28. Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis. Valentine CH; Hellman J; Beasley-Topliffe LK; Bagchi A; Warren HS Mol Med; 2006; 12(9-10):252-8. PubMed ID: 17225874 [TBL] [Abstract][Full Text] [Related]
29. Passive immunotherapy in neonatal calves--I. Safety and potency of a J5 Escherichia coli hyperimmune plasma in neonatal calves. Selim SA; Cullor JS; Oelsner IE Vaccine; 1995; 13(15):1449-53. PubMed ID: 8578825 [TBL] [Abstract][Full Text] [Related]
30. Effect of active and passive immunizations with lipid A and salmonella minnesota Re 595 on gram-negative infections in mice. Hodgin LA; Drews J Infection; 1976; 4(2):5-10. PubMed ID: 789248 [TBL] [Abstract][Full Text] [Related]
31. Potential use of shared antigens for immunization against gram-negative bacillary infections. McCabe WR; DeMaria A; Johns M Prog Clin Biol Res; 1980; 47():107-17. PubMed ID: 6163155 [TBL] [Abstract][Full Text] [Related]
33. The role of heparin in guinea pig gram negative bacterial sepsis. Dunn DL; Mach PA; Cerra FB; Ferguson RM J Surg Res; 1983 May; 34(5):479-85. PubMed ID: 6405100 [TBL] [Abstract][Full Text] [Related]
34. Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota. Konstantinov G; Karacholeva M; Eskenazy M; Ivanova R; Vassileva J; Naumova F; Tekelieva R; Strahilov D Ann Immunol (Paris); 1982; 133D(1):71-6. PubMed ID: 6760795 [TBL] [Abstract][Full Text] [Related]
35. Comparison of serological specificity of anti-endotoxin sera directed against whole bacterial cells and core oligosaccharide of Escherichia coli J5-tetanus toxoid conjugate. Lukasiewicz J; Jachymek W; Niedziela T; Malik-Gebicka M; Dzieciatkowska M; Lugowski C Acta Biochim Pol; 2002; 49(3):721-34. PubMed ID: 12422242 [TBL] [Abstract][Full Text] [Related]
36. Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli. Salles MF; Mandine E; Zalisz R; Guenounou M; Smets P J Infect Dis; 1989 Apr; 159(4):641-7. PubMed ID: 2647860 [TBL] [Abstract][Full Text] [Related]
37. Protective capacity of antibodies against Escherichia coli and K antigens. Kaijser B; Ahlstedt S Infect Immun; 1977 Aug; 17(2):286-9. PubMed ID: 70410 [TBL] [Abstract][Full Text] [Related]
38. Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain. Zhu C; Feng S; Thate TE; Kaper JB; Boedeker EC Vaccine; 2006 May; 24(18):3845-55. PubMed ID: 16112258 [TBL] [Abstract][Full Text] [Related]